Gadoteridol Related Compound A (10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid)
CAS:120041-08-9
Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoi
Formula:
C17H32N4O7
Color and Shape:
White Powder
Molecular weight:
404.2271
Estimated delivery in United States, on Tuesday 7 Jan 2025
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-(2-hydroxypropyl)-
CAS:120041-08-9
Formula:
C17H32N4O7
Molecular weight:
404.4586
Ref: IN-DA000Q77
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-G-3141
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Desgadolinium Gadoteridol
Controlled ProductCAS:120041-08-9
Formula:
C17H32N4O7
Color and Shape:
Neat
Molecular weight:
404.46
Ref: TR-D289885
100mg | 2,142.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025
Desgadolinium gadoteridol
CAS:120041-08-9
Desgadolinium gadoteridol is a contrast agent that is used in magnetic resonance imaging (MRI). It …
Formula:
C17H32N4O7
Purity:
Min. 95%
Molecular weight:
404.5 g/mol
Ref: 3D-VEA04108
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025